ストックスクリーナーアプリを入手
2.33
4.95%
0.11
アフターアワーズ：
4.05
1.72
+73.82%
Sonoma Pharmaceuticals Inc (SNOA) 最新ニュース
Sonoma Pharmaceuticals (SNOA) Expands Reach with UK Product Registration | SNOA Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Major UK Retail Breakthrough: Sonoma's Natural Acne Treatment to Roll Out Across 1,200 Leading Pharmacies - Stock Titan
NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World
Rising Trends of Scar Treatment Market in Worldwide | Top most Key - openPR.com
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
SNOA stock touches 52-week low at $1.84 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $1.84 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Delaware passes law designed to stop more Elon Musks from leaving state - Yahoo Finance
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain - Yahoo Finance
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Significant Growth in Short Interest - Defense World
Sonoma Pharmaceuticals expands agreement with WellSpring By Investing.com - Investing.com Australia
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
Sonoma Pharmaceuticals expands agreement with WellSpring - Investing.com
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph
Breakthrough Approval Sends Monogram Technologies (MGRM) Shares Soaring - Stocks Telegraph
Sonoma Pharmaceuticals (SNOA) Gains In Pre-Hour Trading - Stocks Telegraph
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
Scar Management Market Top PlayersNewmedical Technology - openPR.com
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors - Yahoo Finance
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
SNOA's Wound Care Products Get Regulatory Clearance, LFMD's Q4 Revenue Soars, ATRA On Watch - RTTNews
Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures - TradingView
Sonoma Pharmaceuticals expands into UK market By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals expands into UK market - Investing.com India
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 25% Lower - Simply Wall St
SNOA stock touches 52-week low at $2 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Scar Treatment Market Projected To Witness Massive Growth, - openPR
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
Virpax Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRPX - Benzinga
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff - ACCESS Newswire
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges By Investing.com - Investing.com South Africa
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges - Investing.com
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - ACCESS Newswire
How Sonoma Pharmaceuticals Plans to Expand Its Dermatology Footprint at Major 2025 Industry Event - StockTitan
Investor Network: Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Sonoma Pharmaceuticals secures new supply agreement - MSN
SNOA stock touches 52-week low at $2.44 amid market challenges - Investing.com Canada
More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown - Yahoo Finance
Sonoma County earmarks opioid settlement money for treatment, education programs - MSN
CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga
Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) and BrainsWay (NASDAQ:BWAY) - Defense World
4.83%
1.04%
大文字化:
|
ボリューム (24 時間):